Nuvectra is a neuromodulation medical device company focused on the development and commercialization of our neurostimulation technology platform for the treatment of various disorders through stimulation of tissues associated with the nervous system. The Company's neurostimulation technology platform has the capability to provide treatment to patients in several established neurostimulation markets, including spinal cord stimulation, sacral nerve stimulation, deep brain stimulation, and other emerging neurostimulation markets. Nuvectra's Algovita SCS system, or Algovita, is the first application of the Company's stimulation technology platform and is indicated for the treatment of chronic pain of the trunk and limbs.
Gross profit (FY, 2018)
Gross profit margin (FY, 2018), %
Net income (FY, 2018)
EBIT (FY, 2018)
Market capitalization (15-Mar-2019)
Closing stock price (15-Mar-2019)
|USD||Q1, 2017||Q2, 2017||Q3, 2016||Q1, 2017||Q2, 2017||Q3, 2017||Q1, 2018||Q2, 2018||Q3, 2018|
Depreciation and Amortization
Nuvectra revenue breakdown by business segment: 41.1% from NeuroNexus and 58.9% from Nuvectra
When was Nuvectra founded?
Nuvectra was founded in 2016.
How many employees does Nuvectra have?
Nuvectra has 89 employees.
What is Nuvectra revenue?
Latest Nuvectra annual revenue is $48.8 m.
What is Nuvectra revenue per employee?
Latest Nuvectra revenue per employee is $548.7 k.
Who are Nuvectra competitors?
Competitors of Nuvectra include Outset Medical, Cerevo and eSolutions.
Where is Nuvectra headquarters?
Nuvectra headquarters is located at 5830 Granite Pkwy #1100, Plano.
Where are Nuvectra offices?
Nuvectra has an office in Plano.
How many offices does Nuvectra have?
Nuvectra has 1 office.